Niclosamide for Mild to Moderate COVID-19

NCT04399356 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Niclosamide
DRUG: Placebo
OTHER: Telehealth monitoring

Sponsor

Tufts Medical Center